Related Experiment Video

Updated: Aug 24, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease

Rumiko Kurosaki1, Yasuko Muramatsu, Hiroyuki Kato

  • 1Department of Drug Metabolism and Therapeutics, Graduate School and Faculty of Pharmaceutical Sciences, The University of Tokushima, Tokushima, 1-78, Sho-machi, Tokushima 770-8505, Japan.

Pharmacology, Biochemistry, and Behavior
|May 26, 2004
PubMed

Insights

Acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) exposure in mice causes significant dopamine depletion and motor deficits. This neurotoxicity involves dopaminergic neuron loss and altered free radical quenching, offering insights into neurodegeneration.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes Parkinsonism-like symptoms.
  • Understanding MPTP's neurotoxic mechanisms is crucial for developing treatments for neurodegenerative diseases.

Purpose of the Study:

  • To investigate the biochemical, behavioral, and immunohistochemical effects of different 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment schedules in mice.
  • To elucidate the role of free radical quenching in MPTP-induced neurodegeneration.

Main Methods:

  • Mice were subjected to four distinct MPTP hydrochloride administration protocols.
  • Biochemical assays measured dopamine and its metabolites (DOPAC, HVA) in the striatum.
  • Immunohistochemistry assessed tyrosine hydroxylase (TH), dopamine transporter (DAT), glial fibrillary acidic protein (GFAP), and superoxide dismutase (SOD) levels.

Main Results:

  • MPTP treatment at 20 mg/kg four times daily at 2-h intervals induced severe dopamine depletions and behavioral deficits.
  • Immunohistochemistry revealed significant loss of dopaminergic neurons (TH+, DAT+) and increased astrocyte activation (GFAP+) in the striatum and substantia nigra.
  • Altered Cu/Zn-superoxide dismutase (Cu/Zn-SOD) and manganese superoxide dismutase (Mn-SOD) expression suggested a role for free radical imbalance.

Conclusions:

  • Acute, high-dose MPTP administration is a potent model for studying nigrostriatal degeneration and motor abnormalities.
  • MPTP neurotoxicity involves oxidative stress and impaired free radical defense mechanisms.
  • Findings contribute to understanding age-related neurodegeneration and disease progression.

More Related Videos

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...